series-a
Stage
4
Investors
About
Skylark Bio is a biotechnology company focused on developing gene therapies to address the underlying genetic causes of hearing impairment, aiming to enhance or restore natural communication.
Explore Skylark Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.